American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer.
PURPOSE
To update the recommendations on the role of bone-modifying agents in the prevention and treatment of skeletal-related events (SREs) for patients with metastatic breast cancer with bone metastases.
METHODS
A literature search using MEDLINE and the Cochrane Collaboration Library identified relevant studies published between January 2003 and… (More)
Journal of clinical oncology : official journal…
2009
Results of chemotherapy alone, with sequential or concurrent addition of 52 weeks of trastuzumab in the NCCTG N9831 HER-2 positive adjuvant breast cancer trial
EA Perez, VJ Suman, NE Davidson
Annual San Antonio Breast Cancer Symposium…
2009
Safety and activity report of a randomized phase II trial of preoperative anthracycline-based chemotherapy plus lapatinib, trastuzumab or both in HER2 positive breast cancer: CHERLOB Trial